Xspray’s patented method to create amorphous forms of drugs, makes it possible to enter the market long before the generic companies, with a cheaper version of the original drug. The amorphous form of Xspray’s drug renders the original company’s secondary patent, which protects certain crystalline patterns, ineffective. This creates a window over several years, where Xspray becomes sole competitor on a multi billion dollar market.